According to the Virginia Department of Health, the Pfizer vaccine could be approved for use in children aged 12 to 15 as early as next week, but The Virginia Research Center is getting ready to start a new study that would test the effectiveness of lower vaccine doses in kids below the age of 12.
Virginia’s colleges and universities are beginning to announce mandatory fall COVID-19 vaccine policies following the state attorney general’s opinion that higher education institutes can require the vaccine.
You’ll often find Eleanor Love and her team of volunteers spending their weekend mornings collecting flower arrangements from wedding venues, giving a new meaning to the old saying, "something old, something new."
Visiting loved ones in nursing facilities was one of the major sacrifices many people had to make because of the pandemic, but now that restrictions are loosening, experts want families to be prepared for loved ones who may have cognitively or physically declined further in the past year.
But data from the clinics, provided to the Mercury by the Virginia Department of Health and Federal Emergency Management Agency, show participation at the sites have been mixed — and in some cases is declining — despite a steady flow of doses.
As the usage of the Johnson & Johnson vaccine has been paused, doctors say the risk of complications is low for most people but advise paying attention to changes in your body if you received the vaccine within the last three weeks.
On a conference call with reporters, Avula says sooner or later, the approach to vaccinations will change. It will become less about just making the shot available, and more about addressing skepticism.
A patchwork of advice was emerging from governments across Europe and farther afield, a day after the European Union’s drug regulator said there was a “possible link” between the AstraZeneca vaccine and a rare clotting disorder while reiterating the vaccine is safe and effective.